Investor relations pageIR page | no data available |
Founding year | no data available |
Headquarter | , , no data available |
Employees | 71 (as per Q2 2017)no data available |
Sector | Biotechnology, HealthcareBiotechnology, Healthcareno data available |
Ticker | PTIno data available |
Financial year endsFY ends | End of Octoberno data available |
Last Closing Price as per Oct 13, 2017, in USD |
2.07n/a |
Market Capitalisation in million USD |
300n/a |
Enterprise Value in million USD |
0n/a |
Common Shares Outstanding as per May 31, 2017 |
145,136,214n/a |
Preferred Shares Outstanding as per May 31, 2017 |
n/a |
Average Basic Shares Outstanding TTM |
138,690,510n/a |
Average Diluted Shares Outstanding TTM |
139,642,153n/a |
Index Membership |
n/a
|
Revenues | 0n/a |
Gross Profit | 0n/a |
Operating Income | 0n/a |
EBITDA | 0n/a |
Net Profit | 0n/a |
Cash and Cash Equivalents | 0n/a |
Receivables | 0n/a |
Total Current Assets | 0n/a |
PP&E | 0n/a |
Total Assets | 0n/a |
Accounts Payable | 0n/a |
Current Debt | 0n/a |
Total Current Liabilities | 0n/a |
Long-Term Debt | 0n/a |
Total Liabilities | 0n/a |
Total Equity | 0n/a |
Depreciation & Amortisation | 0n/a |
Change in Working Capital | 0n/a |
Operating Cash Flow | 0n/a |
Net Change in PP&E and Intangibles | 0n/a |
Investing Cash Flow | 0n/a |
Dividends Paid | 0n/a |
Financing Cash Flow | 0n/a |
Total Change in Cash | 0n/a |
Free Cash Flow | 0n/a |
Gross Margin | 0.0%n/a |
Operating Margin | 0.0%n/a |
Net Profit Margin | 0.0%n/a |
Return on Equity | 0.0%n/a |
Return on Assets | 0.0%n/a |
Basic EPS | n/a |
Diluted EPS | n/a |
Sales per Share | n/a |
Book Value per Share | n/a |
FCF per Share | n/a |
Dividends per Share | n/a |
Price to Earnings Ratio | n/a |
Price to Sales Ratio | n/a |
Price to Book Value | n/a |
Price to Free Cash Flow | n/a |
EV/EBITDA | n/a |
EV/Sales | n/a |
Book to Market Value | n/a |
Current Ratio | 0.0%n/a |
Liabilities to Equity Ratio | 0.0%n/a |
Debt to Assets Ratio | 0.0%n/a |
in million USD | FY '14 | FY '15 | FY '16 |
---|---|---|---|
|
1,484
|
1,774
|
1,867
|
|
1,096
|
1,216
|
1,321
|
|
387
|
559
|
546
|
|
239
|
309
|
323
|
|
14
|
15
|
2
|
|
52
|
25
|
7
|
|
60
|
19
|
17
|
|
10
|
4
|
0
|
|
0
|
5
|
-1
|
|
13
|
182
|
198
|
|
91
|
142
|
160
|
|
9
|
18
|
6
|
|
-1
|
-1
|
-1
|
|
28
|
4
|
22
|
|
-113
|
35
|
11
|
|
0
|
-16
|
0
|
|
20
|
10
|
17
|
|
-15
|
-10
|
-41
|
|
4
|
0
|
-24
|
|
-117
|
35
|
35
|
|
-2
|
104
|
-3
|
|
-119
|
138
|
32
|
Remarks |
restated on Dec 23, 2016
n/a
calculated values,
|
restated on Dec 23, 2016
n/a
calculated values,
|
restated on Dec 23, 2016
n/a
calculated values,
|
in million USD | FY '14 | FY '15 | FY '16 |
---|---|---|---|
Assets | |||
|
n/a
|
329
|
165
|
|
n/a
|
329
|
401
|
|
n/a
|
370
|
395
|
|
n/a
|
6
|
9
|
|
n/a
|
16
|
22
|
|
n/a
|
1,049
|
991
|
|
n/a
|
877
|
984
|
|
n/a
|
276
|
248
|
|
n/a
|
74
|
0
|
|
n/a
|
1
|
30
|
|
n/a
|
284
|
282
|
|
n/a
|
15
|
12
|
|
n/a
|
40
|
44
|
|
n/a
|
2,615
|
2,590
|
Liabilities and owners' equity | |||
|
n/a
|
0
400000
|
0
0
|
|
n/a
|
462
461800000
|
394
393600000
|
|
n/a
|
9
9000000
|
7
6600000
|
|
n/a
|
106
105900000
|
154
154200000
|
|
n/a
|
21
21200000
|
20
19500000
|
|
n/a
|
598
598300000
|
574
573900000
|
|
n/a
|
2,647
2646700000
|
2,049
2049200000
|
|
n/a
|
75
75200000
|
102
102300000
|
|
n/a
|
79
79100000
|
67
67100000
|
|
n/a
|
80
79900000
|
146
145500000
|
|
n/a
|
3,479
3479200000
|
2,938
2938000000
|
|
n/a
|
0
0
|
0
0
|
|
n/a
|
0
0
|
2
1600000
|
|
n/a
|
0
0
|
591
591400000
|
|
n/a
|
30
30000000
|
0
0
|
|
n/a
|
-821
-820500000
|
-842
-842100000
|
|
n/a
|
-74
-73700000
|
-99
-99300000
|
|
n/a
|
-864
-864200000
|
-348
-348400000
|
|
n/a
|
2,615
2615000000
|
2,590
2589600000
|
Remarks | restated on n/a | restated on Dec 23, 2016 n/a | restated on Jun 9, 2017 n/a |
in million USD | FY '14 | FY '15 | FY '16 |
---|---|---|---|
|
-117
|
35
|
35
|
|
80
|
108
|
113
|
|
25
|
17
|
25
|
|
-10
|
-19
|
-13
|
|
-15
|
-10
|
-37
|
|
-44
|
-221
|
-264
|
|
10
|
14
|
22
|
|
0
|
0
|
1
|
|
10
|
4
|
0
|
|
0
|
-2
|
0
|
|
-2
|
5
|
-1
|
|
-17
|
0
|
0
|
|
0
|
-8
|
0
|
|
-26
|
-27
|
-176
|
|
0
|
-16
|
0
|
|
83
|
263
|
357
|
|
-25
|
142
|
61
|
|
50
|
43
|
-3
|
|
25
|
185
|
58
|
|
-82
|
-147
|
-206
|
|
5
|
7
|
0
|
|
1
|
0
|
2
|
|
0
|
-5
|
0
|
|
-380
|
-170
|
0
|
|
0
|
21
|
0
|
|
-455
|
-294
|
-203
|
|
-11
|
206
|
-3
|
|
-467
|
-88
|
-207
|
|
2,092
|
804
|
41
|
|
-61
|
-20
|
0
|
|
-889
|
0
|
0
|
|
-674
|
-93
|
-592
|
|
0
|
0
|
-51
|
|
0
|
0
|
1
|
|
0
|
0
|
585
|
|
0
|
-538
|
0
|
|
0
|
8
|
0
|
|
0
|
-12
|
0
|
|
468
|
149
|
-16
|
|
0
|
-1
|
0
|
|
468
|
148
|
-16
|
|
-3
|
-1
|
1
|
|
23
|
244
|
-164
|
Remarks |
restated on Dec 23, 2016
n/a
calculated values,
|
restated on Dec 23, 2016
n/a
calculated values,
|
restated on Dec 23, 2016
n/a
calculated values,
|